Phase
1 trial of in situ gene therapy for locally recurrent prostate cancer following radiation therapy failure using sodium/iodide symporter and radioiodine
J.C.
Morris, M.D. Endocrinolgy
Brian
J. Davis, M.D., Ph.D. Radiation
Oncology
Evanthia
X. Galanis, M.D. Medical
Oncology
Michael
M. Lieber, M.D. Urology
Gregory
A. Wiseman, M.D. Nuclear
Medicine
Stephen
J. Russell, M.D., Ph.D. Molecular
Medicine
Torrence
M. Wilson, M.D. Urology
Mark
J. Federspiel, Ph.D. Molecular
Medicine